SOURCE: Research and Markets

Research and Markets

April 05, 2016 11:18 ET

Global Non-Invasive Glucose Monitoring Patent Landscape Analysis -- Trends, Technologies & Opportunities Report -- Key Vendors: Roche Daignostics, Masimo, OrSense

DUBLIN, IRELAND--(Marketwired - April 05, 2016) -  Research and Markets has announced the addition of the "Non-Invasive Glucose Monitoring Patent Landscape" report to their offering.

The patent landscape for non-invasive glucose monitoring is really rich, involving many players exploring various technical approaches, such as IR spectroscopy, photoacoustic or impedance. It includes more than 1,600 patent families filed and involves over 500 applicants.

With 387 million people concerned worldwide by diabetes in 2014 and an ever growing number of diabetics, the market related to diabetes management is considerable and very attractive.

To this date, the conventional technique to measure glucose still involves drawing blood (finger pricking), which can cause pain and discomfort for the patient. While several minimally-invasive devices are now commercially available, bringing to the market a totally non-invasive device would represent a great change for the market and the diabetics.

The renewed IP interest for this topic observed recently shows the desire of players to overcome the same cause of failure faced in the last 3 decades, reliability and accuracy of the technology.

Key Topics Covered:

  • Time evolution of patent publications and countries of patent filings
  • Current legal status of patents
  • Ranking of main patent applicants
  • Joint developments and IP collaboration network of main patent applicants
  • Key patents
  • Granted patents near expiration
  • Relative strength of main companies IP portfolio
  • Non-invasive glucose monitoring IP profiles of 15 major companies with key patents, partnerships, and IP strength and strategy
  • The report also provides an extensive Excel database with all patents analyzed in the study

Benefits of this Report:

  • Understand the IP landscape for non-invasive glucose monitoring
  • Identify key patents
  • Understand trends in non-invasive glucose monitoring IP
  • Classify the major players in noninvasive glucose monitoring IP and the relative strength of their patent portfolio
  • Identify new players in non-invasive glucose monitoring IP
  • Identify IP collaboration networks between key players

Companies Mentioned:

  • Abbott
  • Animas Technologies
  • Bayer Healthcare
  • Cercacor
  • Futrex
  • Google
  • InLight Solutions
  • Integrity Applications
  • Key Player Selection
  • Masimo
  • OrSense
  • Panasonic
  • Roche Diagnostics
  • Samsung Electronics
  • Sensys Medical
  • Toshiba

Report Structure:

1. Introduction

2. Executive Summary

3. IP Overview

4. Main Patent Litigations

5. Non-Invasive Devices for Glucose Monitoring

6. Key Players

7. Conclusions

8. Annex

For more information visit

Sector: Glucose Testing

Image Available:

Contact Information

    Research and Markets
    Laura Wood
    Senior Manager

    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900

    U.S. Fax: 646-607-1907
    Fax (outside U.S.): +353-1-481-1716